Elize W. Lockhorst
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elize W. Lockhorst has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Paul D. Gobardhan
Department of Surgery Amphia Hospital Breda The Netherlands
4 shared publicationsJennifer M. J. Schreinemakers
Department of Surgery Amphia Hospital Breda The Netherlands
3 shared publicationsCornelis Verhoef
Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
2 shared publicationsEva de Bruijn
Department of Surgery Amphia Hospital Breda The Netherlands
2 shared publicationsKlaas M. Govaert
Department of Surgery Maasziekenhuis Pantein Boxmeer The Netherlands
2 shared publicationsLinda Klouwens
Department of Surgery Amphia Hospital Breda The Netherlands
2 shared publications
Latest Publications
- Open Access
- 2 August 2026
- Published by Wiley in Colorectal Disease
- Vol. 28 (8)
Bridge‐to‐surgery in acute right‐sided obstructing colon cancer: A survey of surgeons' perspectives on treatment strategies
Aim: To investigate surgeons' perspectives on the management of right‐sided obstructing colon cancer, with particular focus on their views regarding bridge‐to‐surgery strategies. Methods: A national cross‐sectional descriptive survey study was conducted in the Netherlands between January and October 2024. Questionnaires were distributed among surgeons with an interest in colorectal surgery and surgical trainees specialising in gastrointestinal surgery. Results: Fifty completed questionnaires were analysed; 80% of the respondents were surgeons, 20% were surgical trainees. Emergency resection was reported as the sole treatment option for right‐sided obstructing colon cancer in 4% ( n = 2), while 64% ( n = 32) indicated that emergency resections were performed alongside other treatment strategies. The majority of the respondents preferred a bridge‐to‐surgery strategy, with bowel decompression with nasogastric tube (38%) and ileostomy (38%) being the most favoured strategies. Endoscopic stenting was not offered in 90%, largely due to the lack of trained endoscopists. Conclusion: Management of right‐sided obstructing colon cancer varies considerably, though most surgeons and surgical trainees favour bridge‐to‐surgery approaches. Greater consistency may be achieved through further research and guideline development.
- 2 August 2026
- Published by Wiley in Colorectal Disease
- Vol. 28 (8)
Open AccessBridge‐to‐surgery in acute right‐sided obstructing colon cancer: A survey of surgeons' perspectives on treatment strategies
Aim: To investigate surgeons' perspectives on the management of right‐sided obstructing colon cancer, with particular focus on their views regarding bridge‐to‐surgery strategies. Methods: A national cross‐sectional descriptive survey study was conducted in the Netherlands between January and October 2024. Questionnaires were distributed among surgeons with an interest in colorectal surgery and surgical trainees specialising in gastrointestinal surgery. Results: Fifty completed questionnaires were analysed; 80% of the respondents were surgeons, 20% were surgical trainees. Emergency resection was reported as the sole treatment option for right‐sided obstructing colon cancer in 4% ( n = 2), while 64% ( n = 32) indicated that emergency resections were performed alongside other treatment strategies. The majority of the respondents preferred a bridge‐to‐surgery strategy, with bowel decompression with nasogastric tube (38%) and ileostomy (38%) being the most favoured strategies. Endoscopic stenting was not offered in 90%, largely due to the lack of trained endoscopists. Conclusion: Management of right‐sided obstructing colon cancer varies considerably, though most surgeons and surgical trainees favour bridge‐to‐surgery approaches. Greater consistency may be achieved through further research and guideline development.
- Open Access
Feasibility and Effects of Implementing Multimodal Prehabilitation Before Cytoreductive Surgery in Patients with Ovarian Cancer: The Gynofit Multicenter Study
Background: Cytoreductive surgery (CRS), in combination with chemotherapy, is the main treatment for advanced-stage ovarian cancer. In vulnerable patients, this extensive surgery has a high complication risk and may lead to clinical decline. There is emerging evidence that prehabilitation could be valuable in optimizing the patient’s condition prior to cytoreductive surgery, as is shown in colorectal surgery. However, there is limited evidence in gynecologic oncology. The objective of this study is to evaluate the feasibility and effects of implementing multimodal prehabilitation before cytoreductive surgery in patients with ovarian cancer. Methods: In two Dutch hospitals, 46 patients with ovarian cancer were included during the study period, of whom 32 participated in a multimodal prehabilitation program before CRS. The programs included at least physiotherapy, dietary advice and intoxication cessation. The timing, extent and content of the programs differed. Feasibility was assessed by eligibility and participation rates and adherence to the physiotherapy program. Effectiveness was measured by differences in functional capacity, postoperative outcomes and tolerance to adjuvant chemotherapy. Results: Eligibility rates in both hospitals were 83% and 89%, and participation rates were 68% and 72%. Adherence to the physiotherapy program was moderate and only satisfactory in 55% and 63% of the patients. All fitness endpoint measurements improved compared to the baseline. No significant differences in postoperative outcomes were found between prehabilitation and control patients. Prehabilitation patients appeared to have better tolerance to adjuvant chemotherapy, with fewer dose reductions (21% vs. 73%, p = 0.017) and dose deferrals (39% vs. 46%, not significant) compared to the control group. Conclusions: The implementation of multimodal prehabilitation before CRS is feasible and effective in patients with ovarian cancer with respectable eligibility and participation rates, along with improved functional capacity, even during neoadjuvant chemotherapy.
Open AccessFeasibility and Effects of Implementing Multimodal Prehabilitation Before Cytoreductive Surgery in Patients with Ovarian Cancer: The Gynofit Multicenter Study
Background: Cytoreductive surgery (CRS), in combination with chemotherapy, is the main treatment for advanced-stage ovarian cancer. In vulnerable patients, this extensive surgery has a high complication risk and may lead to clinical decline. There is emerging evidence that prehabilitation could be valuable in optimizing the patient’s condition prior to cytoreductive surgery, as is shown in colorectal surgery. However, there is limited evidence in gynecologic oncology. The objective of this study is to evaluate the feasibility and effects of implementing multimodal prehabilitation before cytoreductive surgery in patients with ovarian cancer. Methods: In two Dutch hospitals, 46 patients with ovarian cancer were included during the study period, of whom 32 participated in a multimodal prehabilitation program before CRS. The programs included at least physiotherapy, dietary advice and intoxication cessation. The timing, extent and content of the programs differed. Feasibility was assessed by eligibility and participation rates and adherence to the physiotherapy program. Effectiveness was measured by differences in functional capacity, postoperative outcomes and tolerance to adjuvant chemotherapy. Results: Eligibility rates in both hospitals were 83% and 89%, and participation rates were 68% and 72%. Adherence to the physiotherapy program was moderate and only satisfactory in 55% and 63% of the patients. All fitness endpoint measurements improved compared to the baseline. No significant differences in postoperative outcomes were found between prehabilitation and control patients. Prehabilitation patients appeared to have better tolerance to adjuvant chemotherapy, with fewer dose reductions (21% vs. 73%, p = 0.017) and dose deferrals (39% vs. 46%, not significant) compared to the control group. Conclusions: The implementation of multimodal prehabilitation before CRS is feasible and effective in patients with ovarian cancer with respectable eligibility and participation rates, along with improved functional capacity, even during neoadjuvant chemotherapy.
- Open Access
- 13 April 2025
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 31 (3) , e70099
Monitoring Vital Signs With Continuous Monitoring After Major Gastrointestinal Surgical Procedures: The Patient, Nurse and Physician Perspective
Background: Patients undergoing major abdominal surgical procedures are at risk of postoperative complications, requiring early recognition. Clinical deterioration is preceded by changes in vital sings, which are measured three times a day by a nurse. Due to the intermittent measuring, this may result in a delay in the recognition of clinical deterioration. Continuous vital sign monitoring through wireless sensors offers a potential solution for earlier recognition.Aim: To evaluate user satisfaction of a new wireless monitoring system measuring vital signs continuously, by both patients and healthcare providers.Design: A prospective, questionnaire‐based study.Methods: From December 2021 to November 2022, user experience questionnaires were administered to patients who underwent major abdominal surgical procedures and received the patch postoperatively. Questionnaires were administered as well to nurses and physicians working on a surgical ward with the patch. Continuous measurements of heart rate, respiratory rate, and temperature were taken using the Sensium wireless patch.Results: A total of 298 respondents completed the questionnaire, 191 patients, 88 nurses, and 19 physicians. Of the patients, 69% had a positive experience with the patch, and 74% felt safer. Sixty‐three percent of the nurses were positive, and 65% had the feeling that they could monitor the patients better this way. Of the physicians, 63% were positive, 32% believed clinical deterioration could be identified earlier.Conclusion: The use of the Sensium wireless patch for continuous monitoring of vital signs postoperatively was found to be feasible and well‐tolerated. Patients, nurses, and physicians reported a positive experience with its use.
- 13 April 2025
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 31 (3) , e70099
Open AccessMonitoring Vital Signs With Continuous Monitoring After Major Gastrointestinal Surgical Procedures: The Patient, Nurse and Physician Perspective
Background: Patients undergoing major abdominal surgical procedures are at risk of postoperative complications, requiring early recognition. Clinical deterioration is preceded by changes in vital sings, which are measured three times a day by a nurse. Due to the intermittent measuring, this may result in a delay in the recognition of clinical deterioration. Continuous vital sign monitoring through wireless sensors offers a potential solution for earlier recognition.Aim: To evaluate user satisfaction of a new wireless monitoring system measuring vital signs continuously, by both patients and healthcare providers.Design: A prospective, questionnaire‐based study.Methods: From December 2021 to November 2022, user experience questionnaires were administered to patients who underwent major abdominal surgical procedures and received the patch postoperatively. Questionnaires were administered as well to nurses and physicians working on a surgical ward with the patch. Continuous measurements of heart rate, respiratory rate, and temperature were taken using the Sensium wireless patch.Results: A total of 298 respondents completed the questionnaire, 191 patients, 88 nurses, and 19 physicians. Of the patients, 69% had a positive experience with the patch, and 74% felt safer. Sixty‐three percent of the nurses were positive, and 65% had the feeling that they could monitor the patients better this way. Of the physicians, 63% were positive, 32% believed clinical deterioration could be identified earlier.Conclusion: The use of the Sensium wireless patch for continuous monitoring of vital signs postoperatively was found to be feasible and well‐tolerated. Patients, nurses, and physicians reported a positive experience with its use.
- Open Access
- 6 December 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (2) , 109521
Long-term outcomes after postponing surgery to optimise patients with acute right-sided obstructing colon cancer
- 6 December 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (2) , 109521
Open AccessLong-term outcomes after postponing surgery to optimise patients with acute right-sided obstructing colon cancer
- Open Access
- 17 July 2024
- Published by Springer Nature in Journal of Anesthesia, Analgesia and Critical Care
- Vol. 4 (1) , 1-7
Carbon footprint in trauma surgery, is there a way to reduce it?
Background: Inhaled anaesthetic agents like sevoflurane contribute for approximately 5% to healthcare’s carbon footprint. Previous studies suggested that the use of these agents should be minimized. Although multiple trauma surgeries can be performed under regional anaesthesia, most are performed under general anaesthesia. This study aims to evaluate the environmental benefits of using regional anaesthesia over general anaesthesia and to compare the associated complication rates. Methods: This retrospective study included all trauma patients (≥ 18 years) who underwent surgical intervention for hand, wrist, hip, or ankle fractures from 2017 to 2021. The hypothetical environmental gain was calculated based on the assumption that all surgeries were performed under regional anaesthesia. Complication rates were compared between regional and general anaesthesia. Results: Of the 2,714 surgeries, 15% were hand, 26% wrist, 36% hip, and 23% ankle fractures. General anaesthesia was used in 95%, regional in 5%. Switching this 95% to regional anaesthesia would reduce the sevoflurane use by 92 k, comparable to driving 406,553 km by car. The complication rate was higher with general anaesthesia compared to regional (7.7% vs 6.9%, p = 0.75). Conclusion: The potential gain of the reduction of sevoflurane in trauma surgeries which can be performed under regional anaesthesia can be significant.
- 17 July 2024
- Published by Springer Nature in Journal of Anesthesia, Analgesia and Critical Care
- Vol. 4 (1) , 1-7
Open AccessCarbon footprint in trauma surgery, is there a way to reduce it?
Background: Inhaled anaesthetic agents like sevoflurane contribute for approximately 5% to healthcare’s carbon footprint. Previous studies suggested that the use of these agents should be minimized. Although multiple trauma surgeries can be performed under regional anaesthesia, most are performed under general anaesthesia. This study aims to evaluate the environmental benefits of using regional anaesthesia over general anaesthesia and to compare the associated complication rates. Methods: This retrospective study included all trauma patients (≥ 18 years) who underwent surgical intervention for hand, wrist, hip, or ankle fractures from 2017 to 2021. The hypothetical environmental gain was calculated based on the assumption that all surgeries were performed under regional anaesthesia. Complication rates were compared between regional and general anaesthesia. Results: Of the 2,714 surgeries, 15% were hand, 26% wrist, 36% hip, and 23% ankle fractures. General anaesthesia was used in 95%, regional in 5%. Switching this 95% to regional anaesthesia would reduce the sevoflurane use by 92 k, comparable to driving 406,553 km by car. The complication rate was higher with general anaesthesia compared to regional (7.7% vs 6.9%, p = 0.75). Conclusion: The potential gain of the reduction of sevoflurane in trauma surgeries which can be performed under regional anaesthesia can be significant.
- Open Access
- 18 June 2024
- Published by Wiley in World Journal of Surgery
- Vol. 48 (8) , 1902-1911
Improving diagnosis of early complications (<1 week) through continuous vital sign monitoring following oncological gastrointestinal surgical procedures
Background: Patients undergoing major oncological abdominal surgery are prone to postoperative complications, making early recognition crucial. Clinical deterioration is often preceded by changes in vital signs, which are typically measured thrice a day by a nurse. However, intermittent measurements may delay recognizing clinical deterioration. Continuous vital parameter monitoring may lead to earlier recognition and management of complications and reduce nursing workload.Objective: To compare vital parameter measurements between ward nurses and a wireless continuous monitoring system (Sensium® wireless patch) and assess whether this patch can detect clinical deterioration earlier in patients with complications in the first postoperative week.Methods: Vital parameters (heart rate, respiratory rate, and temperature) were collected in patients undergoing an oncological resection of the liver, colorectal, or pancreas. Sensium® patch measurements were compared to nurses' measurements to assess the percentages of discordant measurements. In patients with complications in the first postoperative week, time discrepancies between nurses and Sensium® patch measurements were identified in cases of clinical deterioration (respiratory rate ≥15/min, heart rate ≥100/min, and temperature ≥38°C).Results: Among 227 patients, 22% of the patients experienced complications. Nurse and Sensium® measurements were discrepant in 586/2272 measurements (26%). In 506/586 discrepancies (86%), this was due to the respiratory rate (difference ≥4/min). Compared to nurses, the Sensium® patch detected an elevated respiratory rate 14 h earlier and heart rate 2 h earlier within complications in the first postoperative week. For temperature, no difference was observed.Conclusion: Continuous monitoring with the Sensium® wireless patch holds promise for earlier recognition of complications in patients who underwent major oncological abdominal surgery.
- 18 June 2024
- Published by Wiley in World Journal of Surgery
- Vol. 48 (8) , 1902-1911
Open AccessImproving diagnosis of early complications (<1 week) through continuous vital sign monitoring following oncological gastrointestinal surgical procedures
Background: Patients undergoing major oncological abdominal surgery are prone to postoperative complications, making early recognition crucial. Clinical deterioration is often preceded by changes in vital signs, which are typically measured thrice a day by a nurse. However, intermittent measurements may delay recognizing clinical deterioration. Continuous vital parameter monitoring may lead to earlier recognition and management of complications and reduce nursing workload.Objective: To compare vital parameter measurements between ward nurses and a wireless continuous monitoring system (Sensium® wireless patch) and assess whether this patch can detect clinical deterioration earlier in patients with complications in the first postoperative week.Methods: Vital parameters (heart rate, respiratory rate, and temperature) were collected in patients undergoing an oncological resection of the liver, colorectal, or pancreas. Sensium® patch measurements were compared to nurses' measurements to assess the percentages of discordant measurements. In patients with complications in the first postoperative week, time discrepancies between nurses and Sensium® patch measurements were identified in cases of clinical deterioration (respiratory rate ≥15/min, heart rate ≥100/min, and temperature ≥38°C).Results: Among 227 patients, 22% of the patients experienced complications. Nurse and Sensium® measurements were discrepant in 586/2272 measurements (26%). In 506/586 discrepancies (86%), this was due to the respiratory rate (difference ≥4/min). Compared to nurses, the Sensium® patch detected an elevated respiratory rate 14 h earlier and heart rate 2 h earlier within complications in the first postoperative week. For temperature, no difference was observed.Conclusion: Continuous monitoring with the Sensium® wireless patch holds promise for earlier recognition of complications in patients who underwent major oncological abdominal surgery.
- Open Access
- 1 December 2020
- Published by Elsevier in Journal of Pediatric Surgery Case Reports
- Vol. 63
Femoral hernias occur in both genders
- 1 December 2020
- Published by Elsevier in Journal of Pediatric Surgery Case Reports
- Vol. 63
Open AccessFemoral hernias occur in both genders